journal article·2021-12Open access

Quantifying and controlling bond multivalency for advanced nanoparticle targeting to cells

Elliot Y. Makhani, Ailin Zhang, Jered B. Haun

Nano Convergence· Volume 8· Issue 1

Abstract

Abstract Nanoparticles have drawn intense interest as delivery agents for diagnosing and treating various cancers. Much of the early success was driven by passive targeting mechanisms such as the enhanced permeability and retention (EPR) effect, but this has failed to lead to the expected clinical successes. Active targeting involves binding interactions between the nanoparticle and cancer cells, which promotes tumor cell-specific accumulation and internalization. Furthermore, nanoparticles are large enough to facilitate multiple bond formation, which can improve adhesive properties substantially in comparison to the single bond case. While multivalent binding is universally believed to be an attribute of nanoparticles, it is a complex process that is still poorly understood and difficult to control. In this review, we will first discuss experimental studies that have elucidated roles for parameters such as nanoparticle size and shape, targeting ligand and target receptor densities, and monovalent binding kinetics on multivalent nanoparticle adhesion efficiency and cellular internalization. Although such experimental studies are very insightful, information is limited and confounded by numerous differences across experimental systems. Thus, we focus the second part of the review on theoretical aspects of binding, including kinetics, biomechanics, and transport physics. Finally, we discuss various computational and simulation studies of nanoparticle adhesion, including advanced treatments that compare directly to experimental results. Future work will ideally continue to combine experimental data and advanced computational studies to extend our knowledge of multivalent adhesion, as well as design the most powerful nanoparticle-based agents to treat cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (100+)

Show source-provided references
1. H. Sung, J. Ferlay, R.L. Siegel et al., Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 71(3), 209–249 (2021)
2. E.L. Aaronson, G.R. Quinn, C.I. Wong et al., Missed diagnosis of cancer in primary care: Insights from malpractice claims data. J. Healthc. Risk Manag. 39(2), 19–29 (2019)10.1002/jhrm.21385 ↗
3. M.E. Davis, Z. Chen, D.M. Shin, Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7(9), 771–782 (2008)10.1038/nrd2614 ↗
4. S. Sim, N.K. Wong, Nanotechnology and its use in imaging and drug delivery (Review). Biomed. Rep. 14(5), 1–9 (2021)
5. Z. Yu, L. Gao, K. Chen et al., Nanoparticles: a new approach to upgrade cancer diagnosis and treatment. Nanoscale Res. Lett. 16(1), 88 (2021)10.1186/s11671-021-03489-z ↗
6. M. Azizi, H. Dianat-Moghadam, R. Salehi et al., Interactions between tumor biology and targeted nanoplatforms for imaging applications. Adv. Funct. Mater. 30(19), 1910402 (2020)10.1002/adfm.201910402 ↗
7. X. Han, K. Xu, O. Taratula, K. Farsad, Applications of nanoparticles in biomedical imaging. Nanoscale 11(3), 799–819 (2019)10.1039/C8NR07769J ↗
8. Y.-Y. Ma, K.-T. Jin, S.-B. Wang et al., Molecular imaging of cancer with nanoparticle-based theranostic probes. Contrast Media Mol. Imaging 2017, e1026270 (2017)
9. R.M. Crist, S.S.K. Dasa, C.H. Liu, J.D. Clogston, M.A. Dobrovolskaia, S.T. Stern, Challenges in the development of nanoparticle-based imaging agents: characterization and biology. WIREs Nanomed. Nanobiotechnol. 13(1), e1665 (2021)10.1002/wnan.1665 ↗
10. E. Pérez-Herrero, A. Fernández-Medarde, Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. Eur. J. Pharm. Biopharm. 93, 52–79 (2015)10.1016/j.ejpb.2015.03.018 ↗
11. A.S. Thakor, J.V. Jokerst, P. Ghanouni, J.L. Campbell, E. Mittra, S.S. Gambhir, Clinically approved nanoparticle imaging agents. J. Nucl. Med. 57(12), 1833–1837 (2016)10.2967/jnumed.116.181362 ↗
12. A.C. Anselmo, S. Mitragotri, Nanoparticles in the clinic. Bioeng.Transl. Med. 1(1), 10–29 (2016)10.1002/btm2.10003 ↗
13. S.Y.C. Choi, D. Lin, P.W. Gout, C.C. Collins, Y. Xu, Y. Wang, Lessons from patient-derived xenografts for better in vitro modeling of human cancer. Adv. Drug Deliv. Rev. 79–80, 222–237 (2014)10.1016/j.addr.2014.09.009 ↗
14. R.K. Jain, T. Stylianopoulos, Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7(11), 653–664 (2010)10.1038/nrclinonc.2010.139 ↗
15. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotech. 2(12), 751–760 (2007)10.1038/nnano.2007.387 ↗
16. D. Rosenblum, N. Joshi, W. Tao, J.M. Karp, D. Peer, Progress and challenges towards targeted delivery of cancer therapeutics. Nat. Commun. 9(1), 1410 (2018)10.1038/s41467-018-03705-y ↗
17. S.-D. Li, L. Huang, Pharmacokinetics and biodistribution of nanoparticles. Mol. Pharmaceutics. 5(4), 496–504 (2008)10.1021/mp800049w ↗
18. H. Kang, S. Mintri, A.V. Menon, H.Y. Lee, H.S. Choi, J. Kim, Pharmacokinetics, pharmacodynamics and toxicology of theranostic nanoparticles. Nanoscale 7(45), 18848–18862 (2015)10.1039/C5NR05264E ↗
19. R.A. Petros, J.M. DeSimone, Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615–627 (2010)10.1038/nrd2591 ↗
20. R. Bazak, M. Houri, S. El Achy, S. Kamel, T. Refaat, Cancer active targeting by nanoparticles: a comprehensive review of literature. J. Cancer Res. Clin. Oncol. 141(5), 769–784 (2015)10.1007/s00432-014-1767-3 ↗
21. J. Yoo, C. Park, G. Yi, D. Lee, H. Koo, Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers 11(5), 640 (2019)10.3390/cancers11050640 ↗
22. Z. Cheng, A.A. Zaki, J.Z. Hui, V.R. Muzykantov, A. Tsourkas, Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities. Science 338(6109), 903–910 (2012)10.1126/science.1226338 ↗
23. N.L. Adolphi, K.S. Butler, D.M. Lovato et al., Imaging of Her2-targeted magnetic nanoparticles for breast cancer detection: comparison of SQUID-detected magnetic relaxometry and MRI. Contrast Media Mol. Imaging 7(3), 308–319 (2012)10.1002/cmmi.499 ↗
24. C.E. Meacham, S.J. Morrison, Tumour heterogeneity and cancer cell plasticity. Nature 501(7467), 328–337 (2013)10.1038/nature12624 ↗
25. M. Ramezanpour, S.S.W. Leung, K.H. Delgado-Magnero, B.Y.M. Bashe, J. Thewalt, D.P. Tieleman, Computational and experimental approaches for investigating nanoparticle-based drug delivery systems. Biochim. Biophys. Acta 1858(7), 1688–1709 (2016). https://doi.org/10.1016/j.bbamem.2016.02.02810.1016/j.bbamem.2016.02.028 ↗
26. K. Pollinger, R. Hennig, A. Ohlmann et al., Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application. PNAS 110(15), 6115–6120 (2013)10.1073/pnas.1220281110 ↗
27. H. Gao, Z. Yang, S. Zhang et al., Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci. Rep. 3(1), 2534 (2013)10.1038/srep02534 ↗
28. M. Colombo, L. Fiandra, G. Alessio et al., Tumour homing and therapeutic effect of colloidal nanoparticles depend on the number of attached antibodies. Nat. Commun. 7(1), 13818 (2016)10.1038/ncomms13818 ↗
29. C. Tassa, J.L. Duffner, T.A. Lewis et al., Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjugate Chem. 21(1), 14–19 (2010)10.1021/bc900438a ↗
30. S. Muro, T. Dziubla, W. Qiu et al., Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to intercellular adhesion molecule 1. J. Pharmacol. Exp. Ther. 317(3), 1161–1169 (2006)10.1124/jpet.105.098970 ↗
31. A.J. Calderon, V. Muzykantov, S. Muro, D.M. Eckmann, Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. Biorheology 46(4), 323–341 (2009)10.3233/BIR-2009-0544 ↗
32. Q. Zhang, B.M. Reinhard, Ligand density and nanoparticle clustering cooperate in the multivalent amplification of epidermal growth factor receptor activation. ACS Nano 12(10), 10473–10485 (2018)10.1021/acsnano.8b06141 ↗
33. J. Wang, S. Tian, R.A. Petros, M.E. Napier, J.M. DeSimone, The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies. J. Am. Chem. Soc. 132(32), 11306–11313 (2010)10.1021/ja1043177 ↗
34. L. Shang, K. Nienhaus, G.U. Nienhaus, Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 12(1), 5 (2014)10.1186/1477-3155-12-5 ↗
35. C. Contini, J.W. Hindley, T.J. Macdonald, J.D. Barritt, O. Ces, N. Quirke, Size dependency of gold nanoparticles interacting with model membranes. Commun. Chem. 3(1), 1–12 (2020)10.1038/s42004-020-00377-y ↗
36. W. Jiang, B.Y.S. Kim, J.T. Rutka, W.C.W. Chan, nanoparticle-mediated cellular response is size-dependent. Nat. Nanotech. 3(3), 145–150 (2008)10.1038/nnano.2008.30 ↗
37. J.B. Haun, G.P. Robbins, D.A. Hammer, Engineering therapeutic nanocarriers with optimal adhesion for targeting. J. Adhes. 86(1), 131–159 (2010)10.1080/00218460903510414 ↗
38. E.A. Simone, T.D. Dziubla, V.R. Muzykantov, Polymeric carriers: role of geometry in drug delivery. Expert Opin. Drug Deliv. 5(12), 1283–1300 (2008)10.1517/17425240802567846 ↗
39. X. Huang, X. Teng, D. Chen, F. Tang, J. He, The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31(3), 438–448 (2010)10.1016/j.biomaterials.2009.09.060 ↗
40. S.E.A. Gratton, P.A. Ropp, P.D. Pohlhaus et al., The effect of particle design on cellular internalization pathways. PNAS 105(33), 11613–11618 (2008)10.1073/pnas.0801763105 ↗
41. S. Barua, J.-W. Yoo, P. Kolhar, A. Wakankar, Y.R. Gokarn, S. Mitragotri, Particle shape enhances specificity of antibody-displaying nanoparticles. PNAS 110(9), 3270–3275 (2013)10.1073/pnas.1216893110 ↗
42. P. Kolhar, A.C. Anselmo, V. Gupta et al., Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. PNAS 110(26), 10753–10758 (2013)10.1073/pnas.1308345110 ↗
43. A.J. Thompson, E.M. Mastria, O. Eniola-Adefeso, The margination propensity of ellipsoidal micro/nanoparticles to the endothelium in human blood flow. Biomaterials 34(23), 5863–5871 (2013)10.1016/j.biomaterials.2013.04.011 ↗
44. B.D. Chithrani, A.A. Ghazani, W.C.W. Chan, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6(4), 662–668 (2006)10.1021/nl052396o ↗
45. Y. Qiu, Y. Liu, L. Wang et al., Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 31(30), 7606–7619 (2010)10.1016/j.biomaterials.2010.06.051 ↗
46. S. Muro, C. Garnacho, J.A. Champion et al., Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol. Ther. 16(8), 1450–1458 (2008)10.1038/mt.2008.127 ↗
47. S. Hong, P.R. Leroueil, I.J. Majoros, B.G. Orr, J.R. Baker, M.M. Banaszak Holl, The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 14(1), 107–115 (2007)10.1016/j.chembiol.2006.11.015 ↗
48. J.B. Haun, L.R. Pepper, E.T. Boder, D.A. Hammer, Using engineered single-chain antibodies to correlate molecular binding properties and nanoparticle adhesion dynamics. Langmuir 27(22), 13701–13712 (2011)10.1021/la202926m ↗
49. M. Koets, K. van Ommering, L. Wang, E. Testori, T.H. Evers, M.W.J. Prins, Influence of dsDNA fragment length on particle binding in an evanescent field biosensing system. Analyst 139(7), 1672–1677 (2014)10.1039/C3AN01999C ↗
50. K. Abstiens, M. Gregoritza, A.M. Goepferich, Ligand Density and linker length are critical factors for multivalent nanoparticle-receptor interactions. ACS Appl. Mater. Interfaces 11(1), 1311–1320 (2019)10.1021/acsami.8b18843 ↗
51. C.H. Kapadia, S. Tian, J.L. Perry, J.C. Luft, J.M. DeSimone, Role of linker length and antigen density in nanoparticle peptide vaccine. ACS Omega 4(3), 5547–5555 (2019)10.1021/acsomega.8b03391 ↗
52. C.M. Csizmar, J.R. Petersburg, T.J. Perry, L. Rozumalski, B.J. Hackel, C.R. Wagner, Multivalent ligand binding to cell membrane antigens: defining the interplay of affinity, valency, and expression density. J. Am. Chem. Soc. 141(1), 251–261 (2019)10.1021/jacs.8b09198 ↗
53. D.T. Wiley, P. Webster, A. Gale, M.E. Davis, Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor. Proc. Natl. Acad. Sci. USA 110(21), 8662–8667 (2013)10.1073/pnas.1307152110 ↗
54. J.B. Haun, D.A. Hammer, Quantifying nanoparticle adhesion mediated by specific molecular interactions. Langmuir 24(16), 8821–8832 (2008)10.1021/la8005844 ↗
55. A.-M. Chacko, E.D. Hood, B.J. Zern, V.R. Muzykantov, Targeted nanocarriers for imaging and therapy of vascular inflammation. Curr. Opin. Colloid Interface Sci. 16(3), 215–227 (2011)10.1016/j.cocis.2011.01.008 ↗
56. B.J. Zern, A.-M. Chacko, J. Liu et al., Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation. ACS Nano 7(3), 2461–2469 (2013)10.1021/nn305773f ↗
57. D.R. Elias, A. Poloukhtine, V. Popik, A. Tsourkas, Effect of ligand density, receptor density, and nanoparticle size on cell targeting. Nanomedicine 9(2), 194–201 (2013)10.1016/j.nano.2012.05.015 ↗
58. A.M. Alkilany, L. Zhu, H. Weller et al., Ligand density on nanoparticles: a parameter with critical impact on nanomedicine. Adv. Drug. Deliv. Rev. 143, 22–36 (2019)10.1016/j.addr.2019.05.010 ↗
59. D.M. Eckmann et al., Multiscale modeling of protein membrane interactions for nanoparticle targeting in drug delivery. Curr. Opin. Struct. Biol. 64, 104–110 (2020). https://doi.org/10.1016/j.sbi.2020.06.02310.1016/j.sbi.2020.06.023 ↗
60. G.I. Bell, Models for the specific adhesion of cells to cells. Science 200(4342), 618–627 (1978). https://doi.org/10.1126/science.34757510.1126/science.347575 ↗
61. G.I. Bell, M. Dembo, P. Bongrand, Cell adhesion. competition between nonspecific repulsion and specific bonding. Biophys. J. 45(6), 1051–1064 (1984). https://doi.org/10.1016/S0006-3495(84)84252-610.1016/S0006-3495(84)84252-6 ↗
62. R. Merkel, P. Nassoy, A. Leung, K. Ritchie, E. Evans, Energy landscapes of receptor-ligand bonds explored with dynamic force spectroscopy. Nature 397, 50–53 (1999)10.1038/16219 ↗
63. R. Alon, D.A. Hammer, T.A. Springer, Lifetime of the Pselectin-carbohydrate bond and its response to tensile force in hydrodynamic flow. Nature 374, 539–542 (1995)10.1038/374539a0 ↗
64. E. Evans, K. Ritchie, R. Merkel, Sensitive force technique to probe molecular adhesion and structural linkages at biological interfaces. Biophys. J. 68, 2580–2587 (1995)10.1016/S0006-3495(95)80441-8 ↗
65. E. Evans, K. Ritchie, Dynamic strength of molecular adhesion bonds. Biophys. J. 72, 1541–1555 (1997)10.1016/S0006-3495(97)78802-7 ↗
66. E.L. Florin, V.T. Moy, H.E. Gaub, Adhesion forces between individual ligand-receptor pairs. Science 264, 415–417 (1994)10.1126/science.8153628 ↗
67. S.N. Zhurkov, Kinetic concept of the strength of solids. Int. J. Fract. 26, 295–307 (1984). https://doi.org/10.1007/BF0096296110.1007/BF00962961 ↗
68. V.T. Turitto, An improved model for analyzing platelet deposition on glass surfaces. Ind. Eng. Chem. Fundamen. 14(3), 275–276 (1975). https://doi.org/10.1021/i160055a02410.1021/i160055a024 ↗
69. F. Wang, D.P. Landau, Efficient, multiple-range random walk algorithm to calculate the density of states. Phys. Rev. Lett. 86(10), 2050–53 (2001). https://doi.org/10.1103/PhyFsRevLett.86.205010.1103/PhyFsRevLett.86.2050 ↗
70. D.J. Diestler, E.W. Knapp, Statistical thermodynamics of the stability of multivalent ligand-receptor complexes. Phys. Rev. Lett. 100, 178101 (2008)10.1103/PhysRevLett.100.178101 ↗
71. R.H. Kramer, J.W. Karpen, Spanning binding sites on allosteric proteins with polymer-linked ligand dimers. Nature 395, 710 (1998)10.1038/27227 ↗
72. S. Wang, E.E. Dormidontova, Nanoparticle design optimization for enhanced targeting: Monte Carlo simulations. Biomacromolecules 11(7), 1785–95 (2010)10.1021/bm100248e ↗
73. P.I. Kitov, D.R. Bundle, On the nature of the multivalency effect: a thermodynamic model. J. Am. Chem. Soc. 125, 16271–16284 (2003)10.1021/ja038223n ↗
74. D. van Effenterre, D. Roux, Adhesion of colloids on a cell surface in competition for mobile receptors. Europhys. Lett. 64, 543–549 (2003)10.1209/epl/i2003-00268-x ↗
75. J. Huskens et al., A model for describing the thermodynamics of multivalent host-guest interactions at interfaces. J. Am. Chem. Soc. 126, 6784–6797 (2004)10.1021/ja049085k ↗
76. H.P. Deutsch, K. Binder, Interdiffusion and self-diffusion in polymer mixtures: a monte carlo study. J. Chem. Phys. 94(3), 2294–2304 (1991). https://doi.org/10.1063/1.45990110.1063/1.459901 ↗
77. K.A. Welp, R.P. Wool, S.K. Satija, S. Pispas, J. Mays, Dynamics of polymer interdiffusion: the ripple experiment. Macromolecules 31(15), 4915–4925 (1998). https://doi.org/10.1021/ma971692n10.1021/ma971692n ↗
78. R. Kimmich, N. Fatkullin, Polymer Chain Dynamics and NMR, in NMR • 3D Analysis • Photopolymerization, vol. 170, ed. by N. Fatkullin (Springer, Berlin, 2004). https://doi.org/10.1007/978-3-540-40000-4_110.1007/978-3-540-40000-4_1 ↗
79. T. Kreer, J. Baschnagel, M. Müller, K. Binder, Monte Carlo simulation of long chain polymer melts: crossover from rouse to reptation dynamics. Macromolecules 34(4), 1105–1117 (2001). https://doi.org/10.1021/ma001500f10.1021/ma001500f ↗
80. E. Evans, Biophys. J. 48(1), 185–192 (1985). https://doi.org/10.1016/S0006-3495(85)83771-110.1016/S0006-3495(85)83771-1 ↗
81. N.K. Lee et al., Optimal confinement for internal polymer binding. Europhys. Lett. 72, 922 (2005)10.1209/epl/i2005-10328-3 ↗
82. W. Sung, P. J. Park, Polymer translocation through a pore in a membrane department of physics, Pohang University of Science and Technology, Pohang 790-784, Korea (1996)
83. A. Sarkar, D.M. Eckmann, P.S. Ayyaswamy, R. Radhakrishnan, Hydrodynamic interactions of deformable polymeric nanocarriers and the effect of crosslinking. Soft Matter 11(29), 5955–5969 (2015). https://doi.org/10.1039/c5sm00669d10.1039/c5sm00669d ↗
84. S. Farokhirad et al., Nanofluid dynamics of flexible polymeric nanoparticles under wall confinement. J. Heat Trans. 141(5), 104–110 (2019). https://doi.org/10.1115/1.404301410.1115/1.4043014 ↗
85. A. Boulbitch, Z. Guttenberg, E. Sackmann, Phys. J. 81, 2732 (2001)
86. K. Lee, Dynamics and kinetics of polymers and biopolymers. Bio J. Korean Phys. Soc. (2018). https://doi.org/10.3938/jkps.73.48810.3938/jkps.73.488 ↗
87. J. Liphardt, S. Dumont, S.B. Smith, I. Tinoco Jr., C. Bustamante, Science 296, 1832 (2002)10.1126/science.1071152 ↗
88. H. Katkar, M. Muthukumar, J. Chem. Phys. 148, 024903 (2018)10.1063/1.4994204 ↗
89. Y. Kim, M.-K. Chae, N.-K. Lee, Y. Jung, A. Johner, Macromolecules 16, 6285 (2017)10.1021/acs.macromol.7b00748 ↗
90. L.C.-L. Lin, N. Gov, F.L.H. Brown, J. Chem. Phys. 124, 074903 (2006)
91. D. Collin, F. Ritort, C. Jarzynski, S.B. Smith, I. Tinoco Jr., C. Bustamante, Nature 437, 231 (2005)10.1038/nature04061 ↗
92. A.J. Goldmann, R.G. Cox, H. Brenner, Slow viscous motion of a sphere parallel to a plane wall II Couette flow. Chem. Eng. Sci. 22, 653–660 (1967)10.1016/0009-2509(67)80048-4 ↗
93. M. Carrion-Vazquez et al., Mechanical and chemical unfolding of a single protein: a comparison. Proc. Natl. Acad. Sci. USA 96, 3694–3699 (1999)10.1073/pnas.96.7.3694 ↗
94. H.-T. Chung, H.-Y. Yu, Binding of a Brownian nanoparticle to a thermally fluctuating membrane surface. Phys. Rev. E. 101(3), 032604 (2020). https://doi.org/10.1103/PhysRevE.101.03260410.1103/PhysRevE.101.032604 ↗
95. S. Farokhirad, R.P. Bradley, R. Radhakrishnan, Thermodynamic analysis of multivalent binding of functionalized nanoparticles to membrane surface reveals the importance of membrane entropy and nanoparticle entropy in adhesion of flexible nanoparticles. Soft Matter 15(45), 9271–9286 (2019). https://doi.org/10.1039/C9SM01653H10.1039/C9SM01653H ↗
96. N. Ramakrishnan, R.W. Tourdot, D.M. Eckmann, P.S. Ayyaswamy, V.R. Muzykantov, R. Radhakrishnan, Biophysically inspired model for functionalized nanocarrier adhesion to cell surface: roles of protein expression and mechanical factors. R. Soc. Open Sci. 3(6), 160260 (2016). https://doi.org/10.1098/rsos.16026010.1098/rsos.160260 ↗
97. K. Müller, D.A. Fedosov, G. Gompper, Margination of micro- and nano-particles in blood flow and its effect on drug delivery. Nature 4, 4871 (2014). https://doi.org/10.1038/srep0487110.1038/srep04871 ↗
98. H. Yuan et al., Variable nanoparticle-cell adhesion strength regulates cellular uptake. Phys. Rev. Lett. 15, 138101 (2010). https://doi.org/10.1103/PhysRevLett.105.13810110.1103/PhysRevLett.105.138101 ↗
99. X. Meng, X. Li, Size limit and energy analysis of nanoparticles during wrapping process by membrane. Nanomaterials (2018). https://doi.org/10.3390/nano811089910.3390/nano8110899 ↗
100. J.F. Martinez-Veracoechea, D. Frenkel, Designing super selectivity in multivalent nano- particle binding. Proc. Nat. Acad. Sci. 108(27), 10963–10968 (2011). https://doi.org/10.1073/pnas.110535110810.1073/pnas.1105351108 ↗